GGrantIndex
← Leaderboards

Sumit K Chanda

Scripps Research Institute, The

$45,754,771
Attributed
$65,443,335
Total exposure
18
Grants
15
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $80.1M · FY201025
$100M$75M$50M$25M$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$137,199,785 · 20

By mechanism

U19$78,667,973 · 4
UM1$25,003,080 · 1
R01$18,585,611 · 6
P01$10,944,447 · 3
P30$1,962,135 · 3
U54$1,043,654 · 1

Most similar at Scripps Research Institute, The

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseCellsViralGenesIn VivoInfectionImmuneMolecularPathway InteractionsPathogenResponseMediatingVirusSignal TransductionImmune ResponseDesignMemberProteinsResearch PersonnelAreaBiochemicalCell TypeFunctional GenomicsGenetic Screening

Grant awards (72)

Reversing Immune Dysfunction for HIV-1 Eradication$5,028,890
UM1 · FY2025 · AI · contact PI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.$846,223
R01 · FY2025 · AI
Reversing Immune Dysfunction for HIV-1 Eradication$5,001,089
UM1 · FY2024 · AI · contact PI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.$839,256
R01 · FY2024 · AI
Reversing Immune Dysfunction for HIV-1 Eradication$4,986,752
UM1 · FY2023 · AI · contact PI
Determinants of HIV-1 innate immune sensing and its role in shaping the lymphoid environment.$922,525
R01 · FY2023 · AI
Functional Genomics$305,953
P30 · FY2023 · CA · contact PI
Center for Antiviral Medicines & Pandemic Preparedness (CAMPP)$67,624,156
U19 · FY2022 · AI · contact PI
Administrative Core$6,781,491
U19 · FY2022 · AI · contact PI
Reversing Immune Dysfunction for HIV-1 Eradication$4,984,542
UM1 · FY2022 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$450,514
U19 · FY2022 · AI · contact PI
Functional Genomics$305,953
P30 · FY2022 · CA · contact PI
Reversing Immune Dysfunction for HIV-1 Eradication$5,001,807
UM1 · FY2021 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$568,804
U19 · FY2021 · AI · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$563,051
R01 · FY2021 · AI · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$379,532
R01 · FY2021 · AI · contact PI
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors$370,994
R01 · FY2021 · CA · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$195,000
U19 · FY2021 · AI · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$860,913
R01 · FY2020 · AI · contact PI
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors$714,132
R01 · FY2020 · CA · contact PI
Development of SMAC mimetics as latency-reversing agents$664,048
R01 · FY2020 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$567,150
U19 · FY2020 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$364,291
U19 · FY2020 · AI · contact PI
Functional Genomics$305,953
P30 · FY2020 · CA · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$861,268
R01 · FY2019 · AI · contact PI
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors$692,707
R01 · FY2019 · CA · contact PI
Development of SMAC mimetics as latency-reversing agents$664,048
R01 · FY2019 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$565,258
U19 · FY2019 · AI · contact PI
A Novel Conformation of the ZIKV Protease Provides a Unique 3D Scaffold for Discovering Allosteric Protease Inhibitors as Direct Anti-virals, via HT and Virtual Screening, and Protein Engineering$243,750
R21 · FY2019 · AI · contact PI
Functional Genomics$204,540
P30 · FY2019 · CA · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$861,892
R01 · FY2018 · AI · contact PI
Discovery and validation of pan-influenza antivirals$749,135
R56 · FY2018 · AI
Early development of small molecule dendritic cell immunopotentiators for the treatment of solid tumors$737,882
R01 · FY2018 · CA · contact PI
Development of SMAC mimetics as latency-reversing agents$664,048
R01 · FY2018 · AI · contact PI
Project 2 - Host-virus networks regulating flu replication and host responses ex vivo$599,112
U19 · FY2018 · AI · contact PI
Regulators of Innate Immune Responses to Gamma-herpesviruses$457,079
P01 · FY2018 · CA · contact PI
Functional Genomics$204,540
P30 · FY2018 · CA · contact PI
Functional Genomics$12,439
P30 · FY2018 · CA · contact PI
Functional Genomics$9,140
P30 · FY2018 · CA · contact PI
Innate Immune Surveillance of HIV-1 During Transmission and Systemic Infection$910,053
R01 · FY2017 · AI · contact PI
Development of SMAC mimetics as latency-reversing agents$663,969
R01 · FY2017 · AI · contact PI
Molecular Determinants of TLR Trafficking$596,636
R01 · FY2017 · AI · contact PI
ISG CONTROL OF FLAVIVIRUS INFECTION$582,216
R01 · FY2017 · AI
Regulators of Innate Immune Responses to Gamma-herpesviruses$468,881
P01 · FY2017 · CA · contact PI
Functional Genomics$204,539
P30 · FY2017 · CA · contact PI
Data Management and Resources Dissemination Core$171,444
U19 · FY2017 · AI · contact PI
Molecular Determinants of TLR Trafficking$769,642
R01 · FY2016 · AI · contact PI
Development of SMAC mimetics as latency-reversing agents$710,559
R01 · FY2016 · AI · contact PI
ISG CONTROL OF FLAVIVIRUS INFECTION$592,343
R01 · FY2016 · AI
Regulators of Innate Immune Responses to Gamma-herpesviruses$418,574
P01 · FY2016 · CA · contact PI
Data Management and Resources Dissemination Core$205,471
U19 · FY2016 · AI · contact PI
Functional Genomics$204,539
P30 · FY2016 · CA · contact PI
ISG CONTROL OF FLAVIVIRUS INFECTION$603,358
R01 · FY2015 · AI
Molecular Determinants of TLR Trafficking$592,829
R01 · FY2015 · AI · contact PI
Regulators of Innate Immune Responses to Gamma-herpesviruses$462,709
P01 · FY2015 · CA · contact PI
Functional Genomics$204,539
P30 · FY2015 · CA · contact PI
Data Management and Resources Dissemination Core$178,212
U19 · FY2015 · AI · contact PI
Global innate immune responses to HIV-1 infection$4,132,294
P01 · FY2014 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$829,875
P01 · FY2014 · AI · contact PI
Molecular Determinants of TLR Trafficking$697,513
R01 · FY2014 · AI · contact PI
ISG CONTROL OF FLAVIVIRUS INFECTION$613,232
R01 · FY2014 · AI
Regulators of Innate Immune Responses to Gamma-herpesviruses$438,983
P01 · FY2014 · CA · contact PI
Data Management and Resources Dissemination Core$199,536
U19 · FY2014 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$978,632
P01 · FY2013 · AI · contact PI
ISG CONTROL OF FLAVIVIRUS INFECTION$610,742
R01 · FY2013 · AI
Systems-based Analysis of Flaviviral Host Restriction$504,788
U54 · FY2013 · AI · contact PI
Data Management and Resources Dissemination Core$197,534
U19 · FY2013 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$943,141
P01 · FY2012 · AI · contact PI
Systems-based Analysis of Flaviviral Host Restriction$538,866
U54 · FY2012 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$86,520
P01 · FY2012 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$854,115
P01 · FY2011 · AI · contact PI
Global Analysis of Cellular Networks Involved In Restriction of HIV Replication$873,644
P01 · FY2010 · AI · contact PI